Our results have shown significantly decreased levels of IL-13 in patients with steatosis, particularly those exhibiting advanced liver fibrosis, highlighting the importance of this pleiotropic cytokine in the pathogenesis of CHC as well. This evidence concerns the gene IL13 and steatosis.